Keifei Pharma | Tesamorelin 2mg (Tesamorelinfei) | Compound Peptide Vial

Advanced Growth Hormone Releasing Hormone (GHRH) Research Compound

Keifei Pharma Tesamorelinfei 2mg is an investigational peptide research compound studied in laboratory environments for its role in growth hormone releasing hormone (GHRH) signalling pathways, pituitary activation mechanisms, and endocrine regulation processes.

Tesamorelin is widely referenced in scientific research exploring growth hormone secretion dynamics, lipid metabolism regulation, and hormonal feedback systems within controlled experimental models.

Developed as a 2mg compound peptide vial, this formulation is designed for laboratory preparation and controlled research applications where endocrine signalling and growth hormone axis activity are of scientific interest.

Keifei Pharma Tesamorelinfei 2mg Compound Peptide Vial

• GHRH analogue research compound studied in endocrine signalling models
• Investigated in growth hormone release and pituitary activation pathways
• Of interest in lipid metabolism and metabolic regulation research
• Explored in hormonal feedback and endocrine axis studies
• 2mg vial format designed for laboratory preparation use
• High-purity investigational formulation from Keifei Pharma
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only

⚖️ DISCLAIMER

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.

This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.